During the current grant period, CCSG developmental funds were used to support the mission of the Cancer Center in 2 categories critical to the advancement of its goals: 1) additional faculty recruitment in disciplines related to the strategic vision of the Center and 2) pilot project grants to stimulate cross-disciplinary research involving population science. Both categories have proven rich opportunities for the Center to strengthen and diversify its research portfolio. Funds requested to support faculty recruitment in strategic areas have enabled the Center to attract top talent by providing a start-up/transition package that has enabled 8 new recruits to have the resources to immediately develop their research programs. Since their arrival at MSK, these 8 investigators have received $23.8M in peer-reviewed funding and produced over 25 manuscripts from their laboratories. Funds requested to support cross-disciplinary pilot projects involving PSR and other Center programs supported 16 projects, covering the broad spectrum of areas of population research that characterize the PSR Program, with multiple awards in each of PSR?s major programmatic themes: 1) cancer etiology and risk; 2) health behavior and symptom control; and 3) health care delivery, access and disparities. The projects were multidisciplinary as a requirement, and in many cases creative cross-disciplinary interactions were formed, matching population scientists with basic laboratory investigators or clinical investigators. Results have been exciting, with 3 of our junior investigators receiving their first NIH grants as a result of the pilot funds provided by this program. To date, 8 peer-reviewed grants have been awarded stemming from the research conducted in these pilot projects (4 NCI, 2 other NIH, 2 ACS). The total direct cost from these grants is $8,816,229. Building on the success in the current grant period, the Center proposes to continue its program in PSR Pilot Project Funding. We also propose a second faculty recruitment initiative to support the recruitment and integration of faculty with expertise in computational biology. This initiative will build on recent, strategic infrastructure investments in computational biology made by MSK.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA008748-55
Application #
10084840
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-01-20
Project End
2023-12-31
Budget Start
2021-01-01
Budget End
2021-12-31
Support Year
55
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Hay, Jennifer L; Baser, Raymond E; Westerman, Joy S et al. (2018) Prevalence and Correlates of Worry About Medical Imaging Radiation Among United States Cancer Survivors. Int J Behav Med :
Pulitzer, Melissa; Geller, Shamir; Kumar, Erica et al. (2018) T-cell receptor-? expression and ??+ T-cell infiltrates in primary cutaneous ?? T-cell lymphoma and other cutaneous T-cell lymphoproliferative disorders. Histopathology 73:653-662
Geller, Shamir; Dickson, Mark A; Busam, Klaus J et al. (2018) Kaposi's Sarcoma After Autologous Stem-Cell Transplantation and Rituximab Treatment. J Oncol Pract 14:565-568
Brand, Christian; Sadique, Ahmad; Houghton, Jacob L et al. (2018) Leveraging PET to image folate receptor ? therapy of an antibody-drug conjugate. EJNMMI Res 8:87
Jiang, Jue; Hu, Yu-Chi; Tyagi, Neelam et al. (2018) Tumor-aware, Adversarial Domain Adaptation from CT to MRI for Lung Cancer Segmentation. Med Image Comput Comput Assist Interv 11071:777-785
Cifani, Paolo; Dhabaria, Avantika; Chen, Zining et al. (2018) ProteomeGenerator: A Framework for Comprehensive Proteomics Based on de Novo Transcriptome Assembly and High-Accuracy Peptide Mass Spectral Matching. J Proteome Res 17:3681-3692
Ito, Kimiteru; Schöder, Heiko; Teng, Rebecca et al. (2018) Prognostic value of baseline metabolic tumor volume measured on 18F-fluorodeoxyglucose positron emission tomography/computed tomography in melanoma patients treated with ipilimumab therapy. Eur J Nucl Med Mol Imaging :
Shah, Gunjan L; Scordo, Michael; Kosuri, Satyajit et al. (2018) Impact of Toxicity on Survival for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 24:142-149
Abraham, Ann; Zhang, Alysandra J; Ahn, Rosa et al. (2018) Media Content Analysis of Marijuana's Health Effects in News Coverage. J Gen Intern Med 33:1438-1440
Maiga, Amelia W; Deppen, Stephen A; Mercaldo, Sarah Fletcher et al. (2018) Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules. JAMA Surg 153:329-334

Showing the most recent 10 out of 8799 publications